Back to today’s briefing

Story perspectives

Gene Therapy Offers Hope for Ciliary Dyskinesia Patients

3/8/2025

40 9

Summary

Story summary

Patients with primary ciliary dyskinesia and CCDC39 mutations face debilitating lung problems due to a missing protein complex, as revealed by researchers at Washington University School of Medicine. Their groundbreaking study proposes gene therapy as a promising solution to restore this vital protein, offering hope for better treatment outcomes. The findings were published in Science Translational Medicine.

1 of 1

Story summary

Patients with primary ciliary dyskinesia and CCDC39 mutations face debilitating lung problems due to a missing protein complex, as revealed by researchers at Washington University School of Medicine. Their groundbreaking study proposes gene therapy as a promising solution to restore this vital protein, offering hope for better treatment outcomes. The findings were published in Science Translational Medicine.